Pooled Analysis Confirms Flibanserin's Unimpressive Efficacy, Raises Measurement Questions: A Commentary on Simon et al.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. What Women Want? The State of the Art regarding the Treatment of Young Women with Hypoactive Sexual Desire Disorder.Pharmacology · 2024
   Review
2. Commentary on Simon et al.Sexual medicine · 2022
   Article
3. Response to Commentary by Spielmans.Sexual medicine · 2022
   Article
4. Commentary on Simon et al.Sexual medicine · 2022
   Article

Corrections and comments

• Reinstatement · 2022-11-01Date of Article and/or Notice Unknown · Notice - Limited or No Information · Retract and Replace · Temporary Removal · Removed · · date of retraction unknown, html overwrite; date of retraction unknown, html page overwrite; article reinstated on unknown date, with no explanatory notice;

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.